Accessibility links

Denmark

Information on Lloyd's in Denmark

About us

The Danish insurance market non-life insurance market in terms of gross direct premiums generated almost EUR 6.3m in premiums in 2011.

More on Lloyd's in Denmark

FERMA 2013 will this year be held in Maastricht (NL) from 29 September to 2 October 2013 and Lloyd’s will be participating by hosting a booth for the duration of the event.

Find out more about FERMA 2013 and how to book appointments with the boxholders attending our stand.

Denmark Country Profile
A summary of Denmark, containing factsheets on the economy, insurance market and Lloyd's business.

Denmark Country Roundup
Summary of recent industry news from the Country Manager, containing insurance and reinsurance news, updates on distribution and local Lloyd's events.

Denmark Market Presentation
Local insights from Jes Anker Mikkelsen opportunities and challenges for Lloyd’s in Denmark

Class Review provides a benchmarking tool for class of business analysis in key territories for Managing Agents. The reports contain detailed comparisons of Lloyd's premium and performance trends against the local market.

Market information email alerts

Register here for email alerts about Denmark.

Crystal - Denmark
Get quick and easy access to regulatory and taxation requirements in Denmark with the Crystal tool. This information is intended for use by Lloyd's market professionals only.

Market Directories
Access the complete list of companies operating in the Lloyd's market in Market Directories.

Risk Locator
Get guidance on identifying the location of risk for regulatory and tax purposes with the Risk Locator.

Dow Jones news from Denmark

Danske Disputes Ruling over Capital Levels

18 Jun 2013
General

Danske Bank A/S (DANSKE.KO) was ordered by the Danish Financial Supervisory Authority to hold billions of Danish kroner in additional equity against potential loan losses, setting up a dispute with the regulator as authorities globally take a tougher line on the ways banks assess risks.

Novo Nordisk Says Safety of Victoza Drug Further Supported

14 Jun 2013
General

Novo Nordisk A/S (NOVO-B.KO), the world's largest maker of insulin, said late Thursday that it presented data further supporting the safety of its Victoza drug, to treat type-2 diabetes, at a scientific workshop in the US.